Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 36.13
-0.84 (-2.27%)
At close: Mar 27, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 19.8 billion as of March 27, 2026. Its market cap has decreased by -26.97% in one year.
Market Cap
19.80B
Enterprise Value
20.58B
Revenue
17.87B
Ranking
n/a
PE Ratio
19.98
Stock Price
36.13
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 19.80B, an increase of 128.66%. That is a compound annual growth rate of 3.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 19.80B | -12.03% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 29.26B |
| Bliss GVS Pharma | 23.66B |
| Novartis India | 23.14B |
| Unichem Laboratories | 21.05B |
| Hikal | 20.41B |
| Kwality Pharmaceuticals | 15.11B |
| Amrutanjan Health Care | 14.94B |
| Shukra Pharmaceuticals | 14.48B |